Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression.
Cancer Biology & Therapy
Akram, Afia Muhammad AM; Iqbal, Zafar Z; Akhtar, Tanveer T; Khalid, Ahmed Mukhtar AM; Sabar, Muhammad Farooq MF; Qazi, Mahmood Hussain MH; Aziz, Zeba Z; Sajid, Nadia N; Aleem, Aamer A; Rasool, Mahmood M; Asif, Muhammad M; Aloraibi, Saleh S; Aljamaan, Khaled K; Iqbal, Mudassar M